Review Article

Oklusi Vena Sentral Retina: Tinjauan Pustaka

Ni Putu Ayu Reza Dhiyantari , Listya Dyah Rihardini

Ni Putu Ayu Reza Dhiyantari
Klinik Mata Ayu Siwi, Nganjuk, Jawa Timur. Email: ayurezareza@gmail.com

Listya Dyah Rihardini
Klinik Mata Ayu Siwi, Nganjuk, Jawa Timur
Online First: March 03, 2020 | Cite this Article
Dhiyantari, N., Rihardini, L. 2020. Oklusi Vena Sentral Retina: Tinjauan Pustaka. Intisari Sains Medis 11(1): 60-65. DOI:10.15562/ism.v11i1.562


Introduction: Central retinal vein occlusion is vascular eye disease commonly found at ophthalmologist daily practice and also responsible for a large percentage of blindness and eye morbidity. Early diagnosis and prompt treatment may elaborate the disease and slow down disease progression.

Methods: Literature review was carried out, where studies were identified through searching the PubMed, Google Scholar and Proquest database using the keywords: “central retinal vein occlusion”, “anti-VEGF”, “intraocular corticosteroid”, “retinal imaging”, “macular oedema”. Inclusion criteria include any reviews on CRVO. Exclusion criteria was reviews which were published more than 10 years ago. From 75 reviewed journals, 55 journals were included. The literatures were then analysed systematically based on the results of previous studies.

Results: CRVO can be diagnosed clinically based on anamnesis, general physical examination to evaluate risk factors related to the disease and also based on routine ophthalmologic examination. Advanced imaging modalities are useful mainly to evaluate severity of the disease, to choose treatment modalities and also to evaluate disease response to therapy. CRVO management has two main goals, namely (1) to identify major risk factor underlying the disease and control it, (2) to diagnose sight threatening complications of CRVO, such as macular oedema and neovascularisation and to manage them. 

Conclusion: Current CRVO treatment modalities includes anti-VEGF and corticosteroid implants have been extensively studied in big clinical trials and already proven clinically to treat CRVO related macular oedema.

 

Pendahuluan: Oklusi vena sentral mata (central retinal vein occlusion/CRVO) merupakan penyakit vaskular mata yang sering dijumpai pada praktek sehari-hari dan bertanggung jawab atas sejumlah kebutaan dan morbiditas pada mata sehingga diagnosis dini dan penatalaksanaan yang tepat dapat meningkatkan keberhasilan terapi dan mencegah komplikasi lebih lanjut

Metode: Metodologi penulisan yang digunakan adalah tinjauan pustaka. Sumber literatur terdiri dari jurnal-jurnal yang relevan dari search engine PubMed, Google Scholar dan Proquest. Kata kunci yang digunakan adalah “central retinal vein occlusion”, “anti-VEGF”, “kortikosteroid intraocular”, “pencitraan retina”, “edema makula”. Kriteria inklusi adalah semua tinjauan mengenai CRVO. Kriteria eksklusi adalah literatur yang diterbitkan lebih dari 10 tahun terakhir. Dari 75 jurnal yang ditinjau, 55 ditemukan cocok sebagai referensi untuk makalah ini. Informasi yang dikumpulkan dicatat dan dianalisis untuk validitas dan reliabilitas, ditafsirkan dan disusun menjadi satu kajian literatur ilmiah.

Hasil: Diagnosis CRVO dapat ditegakkan secara klinis berdasarkan anamnesis, pemeriksaan fisik umum, serta pemeriksaan ophthalmologis rutin. Pemeriksaan pencitraan penunjang dibutuhkan terutama untuk menilai derajat keparahan penyakit, mempertimbangkan tindakan atau pengobatan, serta berguna dalam menilai respon terapi. Penatalaksanaan CRVO memiliki dua tujuan utama yaitu mengidentifikasi dan mengontrol faktor risiko mayor yang mencetuskan CRVO serta mendiagnosis dan menangani komplikasi yang mengancam penglihatan, terutama edema makula dan neovaskularisasi.

Kesimpulan: Penatalaksanaan CRVO saat ini sudah mengalami perkembangan yang pesat dengan banyaknya modalitas baru termasuk anti-VEGF dan implant kortikosteroid yang telah terbukti secara klinis mampu mengobati edema makula terkait CRVO

References

Jenkins T, Su D, Klufas M. RVO Overview: Epidemiology, risk factors, and clinical features of this common cause of retinal vascular disease. Retina Today. 2018, Apr 40-3

Rogers s, McIntosh RL, Cheung N, et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from United States, Europe, Asia, and Australia. Ophthalmology.2010;117(2):313-319.e1.

Kooragayala LM. Central Retinal Vein Occlusion (CRVO). Medscape 2019. Available online at: https://emedicine.medscape .com/article/1223746-overview#a4

Stem MS, Talwar N, Comer GM, Stein JD. A Longitudinal analysis of risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. 2010;30(1):16-22

Buehl W, Sacu S, Schmidt-Erfurt U. Retinal Vein Occlusion. Dev Ophthalmol 2010; 46:54-72

Keren S, Loewenstein A, Coscas G. Pathogenesis, prevention, diagnosis and management of retinal vein occlusion. World J Ophthalmol. 2014;Nov 12;4(4) 92-112

Central vein occlusion study group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:489-91

Hayreh SS, Zimmerman MB. Fundus changes in central retinal vein occlusion. Retina 2015;35(1):29-42

Hayreh SS, Podhajsky Pa, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011;111: 1087-95

Shroff D, Kothari A, Bhatia G, Gupta C. Clinical Diagnosis of Retinal Vein Occlusion. International Journal of Ophthalmic Research 2016; 2 (2): 137-142. Available online at: www.ghrnet.org/index.php/IJOR/article/view/1548/2043

American Academy of Ophtalmology Preferred Practice Pattern Comittee. Preferred Practice Pattern® Guidelines. Retinal Vein Occlusions . San Francisco, CA: American Academy of Ophthalmology; 2016. Available at: www.aao.org/ppp

Schütze C, Schmidt-Erfurt U. Imaging for BRVO and CRVO.: OCT images layers of the retina that are relevant to the evaluation of RVO. Retina today. 2011, May 63-8

Pichi F. Central Retinal Vein Occlusion. AAO Eyewiki. 2019 available online at: www.eyewiki.aao.org/w/index.php?title=Central_Retinal_Vein_Occlusion

Ashraf M, Souka AAR, Singh RP. Central Retinal Vein Occlusion: Modifying Current Treatment Protocols. Eye; 2016: 30: 505-514

Thorell MR, Goldhardt R. Update in the Management of Macular Edema Following Retinal Vein Occlusions. Curr Ophthalmol Rep. 2016 March; 4(1): 38-47

Maggio E, Polito A, Guerriero M, Pertile G. Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12 month follow-up and prognostic factors. Opththalmologica.2014;232;207-15

Gallemore RP, Wallsh J, Behnam S, Gallemore E. What The Clinical Trials Tell Us- Demystifying the studies for some practical clinical guidelines. Retin today. 2013 Apr:64-7

Ip MS, Scott IU, VanVeldhuisen PC, et al. A Randomized trial comparing the efficacy and savety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standart care vs Corticosteroid for Retinal Vein Occlusion. Arch Ophthalmol. 2009;127:1101-14

Gado AS, Macky TA. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. Clinical and Experimental Ophthalmology. 2014. Available at https://doi.org/10.1111/ceo.12311

Ding X et al. Prospective study of intraviteral triamcinolone acetonid versus bevacizumab for macular edema secondary to central retinal vein occlusion. Retina; 2011:31(5):838-845

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Cental Vein Occlusion Study Group M report. Ophthalmology. 1995; 102;1425-33

Esmaili DD, Boyer DS. Recent advances in understanding and managing retinal vein occlusions. F1000Res. 2018;7:467


No Supplementary Material available for this article.
Article Views      : 386
PDF Downloads : 275